<unk> , also known as endocrine therapy, is a form of hormone therapy that is used in the treatment of breast cancer. Modalities include antiestrogens or<unk>  blockers such as selective<unk>  receptor modulators (SERMs) like tamoxifen, selective<unk>  receptor degraders like fulvestrant, and aromatase inhibitors like anastrozole and ovariectomy. A breast biopsy is tested for whether the cancer cells contain<unk>  or progesterone receptors. A breast cancer that is positive for<unk>  receptors is usually also progesterone receptor positive. This type of cancer is called ER/PR positive, which constitutes approximately 80% of all breast cancers. ER positive cancers use<unk>  to grow, so administering endocrine therapy to a patient diagnosed with ER/PR positive cancer will depress tumor growth. Endocrine therapy should not be confused with menopausal hormone therapy or hormone replacement therapy, which is using<unk>  and/or progesterone supplements to relieve symptoms of menopause.<unk>  feeds breast cancer cells, so when a woman on hormone replacement therapy (HRT) is diagnosed with ER/PR positive breast cancer, her doctor will ask her to stop the HRT. Patients that have tumors small enough to take out with surgery will receive endocrine therapy after their surgery, which is part of adjuvant therapy. Large tumors may receive neo-adjuvant therapy via chemotherapy or radiation to shrink the tumor small enough to operate on.
Estrogen deprivation therapy
Androgen deprivation therapy
Hormone therapy
Hormonal therapy 
Feminizing hormone therapy
Antihormone therapy
Masculinizing hormone therapy
Hormone replacement therapy